Seller record · Telehealth service

CVS MinuteClinic

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: The program page names no filling pharmacy. It says prescriptions go to participating pharmacies of the patient's choice and that supply there is not guaranteed. 2 more criteria also fail; see the table below.

At a glance

CVS MinuteClinicTelehealth service

5/8criteria passed
Price
Not printed before a consultation or sign-up
Sells
semaglutide, tirzepatide, liraglutide, and 4 more
FDA letters
1 on file
Visit CVS MinuteClinicSee all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

The retail clinic network of a national pharmacy chain, selling a weight-loss program in which a board-certified provider evaluates the patient in a paid virtual or in-person visit and prescribes FDA-approved weight-loss medication, including GLP-1s, to a pharmacy of the patient's choice.

Operating entity CVS Pharmacy, Inc.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSCVS MinuteClinic's weight loss program page
S2Prescription gatingPASSCVS MinuteClinic's weight loss program page
S3Pharmacy identificationFAILCVS MinuteClinic's weight loss program page
S4Compounding disclosurePASSCVS MinuteClinic's weight loss program page
S5Analytical documentationFAILCVS MinuteClinic's weight loss program page; CVS MinuteClinic's terms of use page; CVS MinuteClinic's privacy policy
S6Business addressPASSCVS MinuteClinic's privacy policy; CVS MinuteClinic's terms of use page
S7Price disclosureFAILCVS MinuteClinic's weight loss program page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSBoard-certified MinuteClinic providers review each patient's medical history, medications and body mass index and prescribe weight-loss medication only when the patient is eligible, at a virtual or in-person visit.Source: CVS MinuteClinic's weight loss program page.
S2PASSThe program starts with a paid consultation in which the provider reviews the patient's history and goals and then decides whether weight-loss medication is appropriate, so no medication is prescribed before that evaluation.Source: CVS MinuteClinic's weight loss program page.
S3FAILThe program page names no filling pharmacy. It says prescriptions go to participating pharmacies of the patient's choice and that supply there is not guaranteed.Source: CVS MinuteClinic's weight loss program page.
S4PASSThe seller offers no compounded drug through this program: the program page says compounded GLP-1 medications are not prescribed at MinuteClinic and that its providers prescribe FDA approved weight-loss medications.Source: CVS MinuteClinic's weight loss program page.
S5FAILNo certificate, lot number or purity document appears on the program page, the terms of use or the privacy policy.Source: CVS MinuteClinic's weight loss program page; CVS MinuteClinic's terms of use page; CVS MinuteClinic's privacy policy.
S6PASSCVS Pharmacy, Inc. at 1 CVS Drive, Woonsocket, RI 02895, printed in the privacy policy's contact section; the terms of use name the same company.Source: CVS MinuteClinic's privacy policy; CVS MinuteClinic's terms of use page.
S7FAILNo medication price is sold through the program. The page prices the evaluation visit at $29 in cash, with labs extra, and says select GLP-1 medications may cost as little as $149 with a manufacturer coupon at a pharmacy of the patient's choice, while its answers say the actual cost depends on insurance coverage and discount programs.Source: CVS MinuteClinic's weight loss program page.
S8PASSFDA warning letter 663246, September 2023, names CVS Health at its Woonsocket, Rhode Island headquarters and the seller's own website, and alleges that homeopathic pink eye relief drops sold under the CVS Health name are unapproved new drugs. It does not concern weight loss medication. No FDA action has halted the business, and the company continues to operate.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide, tirzepatide, liraglutide, Saxenda, oral semaglutide, Contrave, orlistat.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells liraglutide

Enforcement documents on file: 1 warning letter

FDA warning letter 663246, issued September 2023, to CVS HealthHomeopathic pink eye relief drops sold under the CVS Health name on CVS MinuteClinic's website are unapproved new drugs, and are adulterated because a contract manufacturer made them outside current good manufacturing practice.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit CVS MinuteClinic

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.